Po-704-01 clinical course of patients with hypertrophic cardiomyopathy away from tertiary referral care

Hypertrophic cardiomyopathy (HCM) is one of the most common genetic heart diseases characterized by asymmetric left ventricular hypertrophy (LVH). Advances in diagnosis and management have made HCM a manageable disease with reduced morbidity and mortality. The clinical course of HCM mainly derives from studies in tertiary HCM centers. However, these studies are limited due to gaps in follow-up between clinical encounters or loss of follow-up as local physicians resume care.